Ovulation Testing Kits Market Size & Share 2026-2035

Ovulation Testing Kits Market Size

The global ovulation testing kits market was valued at USD 496.2 million in 2025 and is projected to grow from USD 536.7 million in 2026 to USD 1 billion by 2035, expanding at a CAGR of 7.2%, according to the latest report published by Global Market Insights Inc.

This substantial growth is driven by numerous factors such as the increasing prevalence of polycystic ovary syndrome (PCOS) and other hormonal disorders, rising awareness regarding IVF procedures, and growing technological advancements in ovulation testing kits.

Ovulation testing kits are at-home diagnostic devices used to detect the surge of luteinizing hormone (LH) in a woman’s urine or saliva, which occurs just before ovulation. They help identify the most fertile days in the menstrual cycle, assisting individuals or couples trying to conceive. These kits are typically available as strips, midstream tests, or digital devices for easy and quick self-testing.

Leading companies in the ovulation testing kits market include SPD Swiss Precision Diagnostics GmbH, Church & Dwight Co., Inc., Wondfo Biotech Co., Ltd., and Premom Inc. These companies are expanding their market presence by strengthening their at-home fertility testing portfolios, investing in digital and rapid diagnostic innovations, enhancing retail and e-commerce distribution channels, and increasing global reach through affordable solutions and growing adoption in emerging markets.

The market has increased from USD 389.9 million in 2022 and reached USD 457.8 million in 2024, with a historic growth rate of 7.2%. The rising prevalence of polycystic ovary syndrome (PCOS) and other hormonal imbalances is a significant driver for the ovulation testing kits market. PCOS, a leading cause of irregular ovulation and infertility, creates a growing need for reliable and convenient ovulation monitoring solutions. According to the World Health Organization (WHO), PCOS affects approximately 10–13% of women of reproductive age, with nearly 70% of affected individuals remaining undiagnosed globally. This high rate of underdiagnosis increases the demand for accessible at-home tools that help women better understand their ovulation cycles and fertility patterns.

Women with PCOS often experience irregular menstrual cycles, making it difficult to predict ovulation using traditional methods. Ovulation testing kits provide a practical solution by enabling direct detection of hormone fluctuations, especially luteinizing hormone surges. As awareness about hormonal disorders and fertility issues grows, more women are turning toward self-monitoring solutions. This trend, coupled with an increasing focus on early diagnosis and proactive reproductive health management, is expected to drive sustained demand for ovulation testing kits worldwide.

Additionally, the growing awareness and acceptance of in vitro fertilization (IVF) procedures are significantly driving the demand for ovulation testing kits. As more couples seek assisted reproductive technologies to address infertility challenges, the need for accurate ovulation tracking has become increasingly important. Ovulation testing kits play a crucial role in identifying fertile windows, which is essential not only for natural conception but also for optimizing IVF treatment timing.

Increased access to fertility clinics, educational campaigns, and digital health platforms has improved public understanding of reproductive health and available treatment options. Additionally, social trends such as delayed parenthood and rising infertility rates are encouraging individuals to actively monitor their fertility. This growing emphasis on fertility awareness and proactive planning is boosting the adoption of ovulation testing kits as a convenient and effective preliminary step before pursuing advanced reproductive interventions like IVF.
 

Ovulation Testing Kits Market Trends

• Technological advancements are significantly enhancing the accuracy and usability of ovulation testing kits, driving their adoption among consumers. Modern kits now offer improved sensitivity in detecting luteinizing hormone (LH) levels, providing more precise identification of the fertile window. This increased reliability is encouraging more women to depend on these kits for effective fertility tracking.
• Furthermore, the integration of digital features, such as smart displays and app connectivity, has transformed traditional ovulation tests into advanced fertility monitoring tools. These innovations allow users to store, track, and analyze cycle data over time, making ovulation prediction more personalized and convenient.
• Additionally, the development of user-friendly formats, including midstream tests and compact strip designs, has improved ease of use and accessibility. Such advancements cater to both first-time users and experienced individuals seeking fast and simple testing solutions at home.
• Moreover, continuous innovation in biosensing technologies and hormone detection methods is expanding the capabilities of ovulation kits beyond basic testing. These developments, combined with increasing investment in reproductive health technologies, are expected to further accelerate market growth and consumer adoption.

Ovulation Testing Kits Market Analysis

The market by product is categorized into urine-based ovulation testing kits, saliva-based ovulation testing kits, and digital ovulation testing kits. The urine-based ovulation testing kits segment is bifurcated into test strip type, cassette type, and midstream type. Urine-based ovulation testing kits segment garnered USD 271.5 million revenue size in the year 2025.

• Urine-based ovulation testing kits account for the largest share of the market, primarily due to their high accuracy, affordability, and widespread accessibility. These kits effectively detect luteinizing hormone (LH) surges and are available in user-friendly formats such as test strips, cassettes, and midstream devices. Their easy availability across pharmacies and online platforms further supports consistent consumer adoption.
• The ovulation testing kits market from saliva-based ovulation testing segment accounted for USD 91 million in 2025 and is projected to expand at a CAGR of 6.9% from 2026 to 2035. Saliva-based ovulation testing kits are gaining gradual traction owing to their non-invasive and reusable nature. These kits analyze hormone-related changes through saliva patterns, making them a cost-effective option over repeated use. However, comparatively lower awareness and concerns regarding accuracy slightly limit their broader market penetration.
• The digital ovulation testing segment accounted for USD 133.7 million in 2025 and is projected to expand at a CAGR of 7.6% from 2026 to 2035. Digital ovulation testing kits are witnessing significant growth driven by technological advancements and increasing preference for smart health solutions. These kits offer enhanced precision, clear results, and often integrate with mobile applications for cycle tracking. Their convenience and ability to provide personalized fertility insights make them increasingly popular among modern users.

Based on sales channel, the ovulation testing kits market is divided into brick and mortar and e-commerce. The brick and mortar segment of the market is forecasted to reach USD 567.1 million by 2035, showcasing robust growth.

• Brick-and-mortar sales channels continue to play a crucial role in the distribution of ovulation testing kits, driven by consumer preference for immediate product availability and in-person purchase. Pharmacies, supermarkets, and specialty health stores offer trusted access to these kits, often supported by pharmacist guidance. This channel is particularly relevant in regions where digital adoption is limited.
• Additionally, physical stores enhance consumer confidence by allowing direct product comparison and brand trust. Promotional activities and visibility on retail shelves further contribute to steady sales through this channel. Despite the rise of online platforms, offline distribution remains a key contributor to overall market presence.
• The E-commerce segment accounted for USD 206.9 million in 2025 and is projected to expand at a CAGR of 7.8% from 2026 to 2035. E-commerce is gaining strong momentum as a sales channel for ovulation testing kits, supported by the growing shift toward online shopping and home-based healthcare solutions. Online platforms provide a wide variety of products, competitive pricing, and discreet purchasing, which is especially valued for personal health items. Convenience and doorstep delivery further drive adoption.

Based on end use, the ovulation testing kits market is bifurcated into hospitals and fertility clinics, home care and other end users. The hospital and fertility clinicssegment accounted for USD 296.7 million in 2025.

• Hospitals and fertility clinics account for a major share of the market due to their central role in fertility assessment and assisted reproductive procedures. These settings rely on accurate ovulation monitoring as part of diagnosis and treatment planning, particularly for patients undergoing infertility treatments. Professional supervision further ensures reliable usage and interpretation of results.
• Additionally, increasing patient visits for reproductive health concerns and the growing number of fertility clinics are strengthening demand within this segment. The availability of advanced diagnostic support and trained healthcare professionals enhances trust, making these facilities a primary point of care for ovulation tracking and fertility management.
• The home care segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 7.1% over the forecast period. Home care is emerging as a highly preferred end-use segment, driven by increasing consumer inclination toward self-monitoring and privacy in reproductive health. Ovulation testing kits enable convenient at-home use, eliminating the need for frequent clinical visits while allowing women to track their fertility cycles independently.
• Furthermore, rising awareness about fertility planning and the availability of easy-to-use, affordable kits are boosting adoption in this segment. The growth of digital health tools and e-commerce platforms is further supporting home-based usage, making ovulation tracking more accessible and personalized for a broader population.

North America Ovulation Testing Kits Market

The North America region accounted for 40.5% of the market in 2025. The ovulation testing kits industry in North America is experiencing robust expansion.

• The U.S. ovulation testing kits industry was valued at USD 141.7 million and USD 153 million in 2022 and 2023, respectively. The market size reached USD 179.2 million in 2025, growing from USD 165.7 million in 2024, and is anticipated to grow at a CAGR of 7% from 2026 to 2035.
• The rising prevalence of polycystic ovary syndrome (PCOS) and other hormonal imbalances in North America is significantly driving demand for ovulation testing kits. Conditions such as PCOS often disrupt ovulation cycles, making it challenging for women to predict fertile windows naturally. This has increased reliance on ovulation tracking solutions for accurate fertility planning.
• Additionally, growing diagnosis rates due to advanced healthcare infrastructure and increased awareness have brought more women into fertility management pathways. Women diagnosed with hormonal disorders frequently require tools to monitor ovulation irregularities, boosting the adoption of home-based ovulation kits. These kits provide convenient and real-time insights into hormonal fluctuations.
• Moreover, lifestyle changes, stress, and increasing obesity rates in North America have contributed to hormonal imbalances, further escalating PCOS prevalence. This has led to a broader consumer base seeking non-invasive and cost-effective fertility monitoring options. As a result, ovulation testing kits are becoming an essential component of reproductive health management in the region.

Europe Ovulation Testing Kits Market

Europe ovulation testing kits industry accounted for USD 110.1 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Technological advancements in ovulation testing kits are significantly driving market growth in Europe. Innovations such as digital ovulation kits, smartphone connectivity, and AI-based fertility tracking are enhancing accuracy and user convenience. These advanced features enable women to better understand their cycles and improve conception planning.
• Moreover, European consumers are increasingly inclined toward premium and technologically sophisticated healthcare products. The availability of highly sensitive hormone detection systems and digital result displays has increased confidence in ovulation predictions. This shift toward precision-based fertility monitoring is fueling market expansion.
• Additionally, ongoing research and development by key manufacturers in Europe are leading to the introduction of innovative products with improved usability. Integration with mobile apps and wearable devices further enhances tracking efficiency. These advancements not only improve user experience but also drive widespread adoption of ovulation testing kits across the region.

Asia Pacific Ovulation Testing Kits Market

The Asia Pacific region is projected to show a lucrative growth of about 7.6% during the forecast period.

• The increasing awareness and acceptance of in vitro fertilization (IVF) procedures across Asia Pacific is a key growth driver for ovulation testing kits. As more couples explore assisted reproductive technologies due to delayed pregnancies and infertility issues, the need for accurate ovulation tracking has intensified. Ovulation kits play a vital role in optimizing IVF outcomes through better cycle monitoring.
• Furthermore, government initiatives and expanding fertility clinics in countries such as India, China, and Japan are educating individuals about fertility treatments. This has contributed to a shift from traditional methods to scientific approaches in family planning. Consequently, ovulation kits are gaining popularity as a preparatory tool for IVF cycles.
• In addition, rising disposable income and increasing healthcare accessibility are enabling individuals to invest in fertility-related products. The growing urban population, coupled with awareness campaigns on reproductive health, is encouraging proactive fertility management. This trend continues to strengthen demand for reliable and easy-to-use ovulation testing kits across the region.

Latin America Ovulation Testing Kits Market 

Brazil is experiencing significant growth in the ovulation testing kits industry.

• The growing incidence of fertility issues among women in Brazil is a major factor driving the market. Factors such as delayed pregnancies, lifestyle changes, and environmental influences have contributed to declining fertility rates. This has increased the demand for accessible fertility monitoring solutions.
• Moreover, increasing awareness about reproductive health and fertility challenges is encouraging women to track their ovulation cycles more closely. Ovulation testing kits offer a cost-effective and convenient alternative to clinical fertility assessments. This has made them particularly appealing to women seeking early intervention.
• In addition, limited access to specialized fertility clinics in certain regions has led to higher adoption of at-home testing solutions. Women are increasingly using ovulation kits to better understand their reproductive cycles before seeking medical assistance. This growing reliance on self-monitoring tools is supporting market growth in Brazil.

Middle East and Africa Ovulation Testing Kits Market 

• The increasing prevalence of PCOS and hormonal disorders in Saudi Arabia is playing a crucial role in driving the ovulation testing kits industry. Hormonal imbalances often result in irregular ovulation, making it difficult for women to predict fertility windows. This has led to higher adoption of ovulation testing kits for accurate cycle tracking.
• Additionally, rising awareness about women’s health and fertility issues in the region has prompted more women to seek early diagnosis and management of hormonal conditions. Ovulation kits are increasingly being used as a convenient at-home solution for monitoring reproductive health. This trend is further supported by growing healthcare investments.
• Moreover, shifts in lifestyle patterns, including sedentary habits and dietary changes, are contributing to an increase in endocrine disorders. As more women experience ovulation irregularities, the demand for reliable and easy-to-use fertility tracking tools continues to grow. This is expected to drive sustained market expansion in Saudi Arabia.

Ovulation Testing Kits Market Share

• The top five players, SPD Swiss Precision Diagnostics GmbH, Church & Dwight Co., Inc., Wondfo Biotech Co., Ltd., Ubio Biotechnology Systems, and Premom Inc., collectively accounted for a 55% share of the ovulation testing kits industry, reflecting strong dominance driven by established at-home testing portfolios, extensive retail and e-commerce distribution networks, continuous product innovation, and growing adoption across both developed and emerging markets.
• Ovulation testing kit manufacturers and reproductive health solution providers are increasingly focusing on product innovation, accuracy enhancement, and user-centric design to improve fertility tracking outcomes. Key areas of emphasis include highly sensitive hormone detection technologies, digital ovulation kits, midstream and strip-based formats, and user-friendly interfaces to ensure ease of use and reliable results. In parallel, companies are investing in packaging improvements, shelf-life stability, and distribution efficiency to maintain product quality across retail pharmacies, e-commerce platforms, and healthcare settings.
• Companies, fertility clinics, and healthcare providers are strengthening strategic collaborations to expand access to ovulation testing kits and promote their effective use in fertility planning. Partnerships with digital health platforms, gynecologists, e-commerce retailers, and regional distributors help improve consumer awareness, product availability, and education on ovulation tracking. These initiatives support better adoption of ovulation kits among women seeking natural conception solutions, enhance consistency in fertility monitoring practices, and contribute to the overall growth of the market across both developed and emerging regions.

Ovulation Testing Kits Market Companies

Few of the prominent players operating in the ovulation testing kits industry include:

• Church & Dwight Co., Inc.
• Clinical Guard LLC
• Fairhaven Health, LLC
• Geratherm Medical AG
• Ubio Biotechnology systems
• Hangzhou AllTest Biotech Co., Ltd.
• Mankind Pharma Ltd.
• Nantong Diagnos Biotechnology Co., Ltd.
• Premom Inc.
• QuidelOrtho Corporation
• SPD Swiss Precision Diagnostics GmbH
• Ubio Biotechnology systems

Ubio Biotechnology Systems strengthens its position in the ovulation testing kits market through innovative rapid diagnostic technologies, a diversified reproductive health portfolio, and an expanding presence across emerging and developed healthcare markets.

• Premom Inc

Premom Inc. enhances its position in the ovulation testing kits industry through the integration of digital fertility tracking applications with affordable test kits, providing data-driven insights and improving user engagement in home-based ovulation monitoring.

 Ovulation Testing Kits Industry News: 

• In August 2023, Clearblue expanded its product range with the introduction of the groundbreaking Clearblue Menopause Stage Indicator, a pioneering solution for evaluating a woman's probable menopause phase based on her urine FSH levels, age, and menstrual history. This product launch was geared towards both enriching the company's product portfolio and boosting its revenue.

The ovulation testing kits market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

• Urine-based ovulation testing kits
  • Test strip type
  • Cassette type
  • Midstream type
• Saliva-based ovulation testing kits
• Digital ovulation testing kits

Market, By Sales Channel

• Brick and mortar

• E-commerce

Market, By End use

• Hospitals and fertility clinics
• Home care
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE